2011
DOI: 10.1007/s00432-011-1007-z
|View full text |Cite
|
Sign up to set email alerts
|

Expression of cathepsin D and E-cadherin in primary laryngeal cancers correlation with neck lymph node involvement

Abstract: Objective The aim of this study was to investigate the relation between Cathepsin D (Cath-D) and E-Cadherin (E-Cad) expression levels in tumor tissue and neck lymph node metastasis. This attempt should be made to identify new factors that one could be useful in predicting clinical behavior. Study design In this study, we investigated rates of dying for E-Cad and Cath-D in paraphin blocks of larynx and neck dissection specimens taken from 56 selected patients. Laryngeal specimens dyed by ECad and Cath-D immunoh… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
12
0
1

Year Published

2012
2012
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(13 citation statements)
references
References 32 publications
0
12
0
1
Order By: Relevance
“…Cathepsin D, a lysosomal aspartate proteolytic enzyme that is similar to cathepsin B, also plays an important role in invasion and metastasis of cancer. It is up-regulated in metastasis of some malignant tumors, including primary laryngeal cancers correlated with neck lymph node involvement [36], gastric cancer with lymphatic and/or blood vessel invasion [37], and breast cancer. Furthermore, Cheng et al [38] found that significant cathepsin D expression occurred in lymph node metastasis versus primary NPC and was significantly correlated with advanced clinical stage, recurrence, and lymph node and distant metastasis.…”
Section: Resultsmentioning
confidence: 99%
“…Cathepsin D, a lysosomal aspartate proteolytic enzyme that is similar to cathepsin B, also plays an important role in invasion and metastasis of cancer. It is up-regulated in metastasis of some malignant tumors, including primary laryngeal cancers correlated with neck lymph node involvement [36], gastric cancer with lymphatic and/or blood vessel invasion [37], and breast cancer. Furthermore, Cheng et al [38] found that significant cathepsin D expression occurred in lymph node metastasis versus primary NPC and was significantly correlated with advanced clinical stage, recurrence, and lymph node and distant metastasis.…”
Section: Resultsmentioning
confidence: 99%
“…The expression of cathepsin D protein is known to promote the transport and metastasis of tumor cells (Paksoy et al, ). In this study, cathepsin D protein expression was significantly increased by treatment with E2 (about 1.3 times) and fludioxonil (about 1.2 times) at 72 h or in a time‐dependent manner compared to a control (0.1% DMSO).…”
Section: Resultsmentioning
confidence: 99%
“…Over-expression of N-cadherin is associated with an invasive capacity of breast tumor by increasing the interactions between tumor cells and stromal cells [ 39 ]. Based on the ability to induce the EMT process, E2 and CYP were found to promote the migration and invasion of Ishikawa cancer cells and to increase the protein expression of metastasis-related genes, such as Cathepsin D and MMP-9 [ 40 , 41 ], in the ER-dependent pathway. Therefore, these results indicate that CYP may induce metastatic processes of endometrial cancer cells including EMT, migration, and invasion, similar to E2.…”
Section: Discussionmentioning
confidence: 99%